EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-5.95%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.24B
AUM Growth
-$312M
(-5.6%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
19.63%
Holding
944
New
50
Increased
219
Reduced
167
Closed
31
Top Buys
| 1 |
Pfizer
PFE
|
$26.7M |
| 2 |
Sunrun
RUN
|
$20.2M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
$19.3M |
| 4 |
Danaher
DHR
|
$14.7M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
$13.5M |
Top Sells
| 1 |
Foot Locker
FL
|
$42.5M |
| 2 |
Walmart
WMT
|
$16M |
| 3 |
Masimo
MASI
|
$15.8M |
| 4 |
Enovis
ENOV
|
$14.8M |
| 5 |
JPMorgan Chase
JPM
|
$14.1M |
Sector Composition
| 1 | Technology | 31.7% |
| 2 | Healthcare | 18.75% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Financials | 9.73% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Eastman Chemical
EMN
$7.93B
| $1.03M | 0.02% |
+9,000
| New | +$1.03M |
|
352
Maravai LifeSciences
MRVI
$363M
| $1.01M | 0.02% |
+28,400
| New | +$1.01M |
|
353
GE Aerospace
GE
$296B
| $1.01M | 0.02% |
17,160
+4,706
| +38% | +$277K |
|
354
Fidelity National Information Services
FIS
$35.9B
| $1.01M | 0.02% |
10,000
| – | – |
|
|
SAGE
355
DELISTED
Sage Therapeutics
SAGE
| $977K | 0.02% |
28,500
+16,500
| +138% | +$566K |
|
356
United Natural Foods
UNFI
$1.75B
| $976K | 0.02% |
23,144
+7,000
| +43% | +$295K |
|
|
MRO
357
DELISTED
Marathon Oil Corporation
MRO
| $971K | 0.02% |
38,096
+16,274
| +75% | +$415K |
|
|
DCBO
358
Docebo
DCBO
$896M
| $964K | 0.02% |
18,900
+5,600
| +42% | +$286K |
|
359
Progyny
PGNY
$1.94B
| $958K | 0.02% |
18,828
+200
| +1% | +$10.2K |
|
360
Bright Horizons
BFAM
$6.64B
| $958K | 0.02% |
7,133
| – | – |
|
361
Citigroup
C
$176B
| $954K | 0.02% |
17,349
+4,816
| +38% | +$265K |
|
362
Zoetis
ZTS
$67.9B
| $948K | 0.02% |
4,943
+595
| +14% | +$114K |
|
|
AMRN
363
Amarin Corp
AMRN
$317M
| $936K | 0.02% |
14,350
+4,450
| +45% | +$290K |
|
364
Nutrien
NTR
$27.4B
| $918K | 0.02% |
+9,000
| New | +$918K |
|
365
PNC Financial Services
PNC
$80.5B
| $907K | 0.02% |
4,753
+1,320
| +38% | +$252K |
|
366
TC Energy
TRP
$53.9B
| $903K | 0.02% |
15,800
-4,400
| -22% | -$251K |
|
367
Travere Therapeutics
TVTX
$1.93B
| $894K | 0.02% |
35,600
| – | – |
|
|
CCXI
368
DELISTED
ChemoCentryx, Inc.
CCXI
| $888K | 0.02% |
35,500
+19,000
| +115% | +$475K |
|
369
Beam Therapeutics
BEAM
$2.11B
| $886K | 0.02% |
14,900
+6,400
| +75% | +$380K |
|
370
Autoliv
ALV
$9.58B
| $881K | 0.02% |
11,368
+2,350
| +26% | +$182K |
|
371
Arch Capital
ACGL
$34.1B
| $877K | 0.02% |
18,100
| – | – |
|
372
Denali Therapeutics
DNLI
$2.26B
| $872K | 0.02% |
26,900
-3,700
| -12% | -$120K |
|
|
KRTX
373
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $870K | 0.02% |
7,070
| – | – |
|
374
Chegg
CHGG
$185M
| $858K | 0.02% |
23,808
+7,000
| +42% | +$252K |
|
375
Sociedad Química y Minera de Chile
SQM
$13.1B
| $855K | 0.02% |
+10,000
| New | +$855K |
|